Literature DB >> 23603616

New anticancer active and selective phenylene-bisbenzothiazoles: synthesis, antiproliferative evaluation and DNA binding.

Livio Racané1, Sandra Kraljević Pavelić, Raja Nhili, Sabine Depauw, Charles Paul-Constant, Ivana Ratkaj, Marie-Hélène David-Cordonnier, Krešimir Pavelić, Vesna Tralić-Kulenović, Grace Karminski-Zamola.   

Abstract

Novel amidino-derivatives of phenylene-bisbenzothiazoles were synthesized and tested for their antiproliferative activity against several human cancer cell lines, as well as DNA-binding properties. The synthetic approach used for preparation of isomeric amidino substituted-phenylene-bis-benzothyazoles 3a-3f was achieved by condensation reaction of isophthaloyl dichloride 1a and terephthaloyl dichloride 1b or with phthalic acid 1c with 5-amidinium-2-aminobenzothiolate 2a and 5-(imidazolinium-2-yl)-2-aminobenzothiolate 2b in good yields. The targeted compounds were converted in the desired water soluble dihydrochloride salts by reaction of appropriate free base with concd HCl in ethanol or acetic acid. All tested compounds (3a-3f) showed antiproliferative effects on tumour cells in a concentration-dependant manner. The strongest activity and cytotoxicity was observed for diimidazolinyl substituted phenylene-bisbenzothiazole compound 3b. These effects were shown to be related to DNA-binding properties, topoisomerase I and II poisoning effects and apoptosis induction. The highest tested selectivity towards tumour cells was observed for the imidazolyl substituted phenylene-benzothiazole 3d that showed no cytotoxic effects on normal fibroblasts making it an excellent candidate for further chemical optimization and preclinical evaluation.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23603616     DOI: 10.1016/j.ejmech.2013.02.026

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  4 in total

1.  Eco-friendly synthesis, in vitro anti-proliferative evaluation, and 3D-QSAR analysis of a novel series of monocationic 2-aryl/heteroaryl-substituted 6-(2-imidazolinyl)benzothiazole mesylates.

Authors:  Livio Racané; Lucija Ptiček; Mirela Sedić; Petra Grbčić; Sandra Kraljević Pavelić; Branimir Bertoša; Irena Sović; Grace Karminski-Zamola
Journal:  Mol Divers       Date:  2018-04-17       Impact factor: 2.943

2.  New insights on the mechanism of quinoline-based DNA Methyltransferase inhibitors.

Authors:  Christina Gros; Laurence Fleury; Virginie Nahoum; Céline Faux; Sergio Valente; Donatella Labella; Frédéric Cantagrel; Elodie Rilova; Mohamed Amine Bouhlel; Marie-Hélène David-Cordonnier; Isabelle Dufau; Frédéric Ausseil; Antonello Mai; Lionel Mourey; Laurent Lacroix; Paola B Arimondo
Journal:  J Biol Chem       Date:  2014-12-18       Impact factor: 5.157

3.  Preclinical in vitro screening of newly synthesised amidino substituted benzimidazoles and benzothiazoles.

Authors:  Livio Racané; Maja Cindrić; Ivo Zlatar; Tatjana Kezele; Astrid Milić; Karmen Brajša; Marijana Hranjec
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

4.  An aromatic imidazoline derived from chloroquinoline triggers cell cycle arrest and inhibits with high selectivity the Trypanosoma cruzi mammalian host-cells infection.

Authors:  Roberto I Cuevas-Hernández; Richard M B M Girard; Luka Krstulović; Miroslav Bajić; Ariel Mariano Silber
Journal:  PLoS Negl Trop Dis       Date:  2021-11-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.